Follow the HLB테라퓨틱스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, HLB테라퓨틱스 has recorded 57 insider filings. Market capitalisation: €216bn. The latest transaction was reported on 10 June 2026 (Other). Among the most active insiders: HLB. Every trade is free.
57
Insider Decl.
0
Thresholds
€49,275
31 ops.
Buy Volume
·
0 ops.
Sell Volume
16Σ signal
Buys €49,275· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,810 of 26,211 companies
16.2
score / 100
Value
16
Quality
17
FCF yld-13%
Earn yld-6.7%
EV/EBITDA·
ROE-5.4%
Gross mgn15%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.